Another piece in the COVID-19 treatment puzzle
- PMID: 35151380
- PMCID: PMC8830900
- DOI: 10.1016/S0140-6736(22)00154-4
Another piece in the COVID-19 treatment puzzle
Conflict of interest statement
We declare no competing interests.
Comment on
-
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.Lancet. 2022 Feb 12;399(10325):665-676. doi: 10.1016/S0140-6736(22)00163-5. Lancet. 2022. PMID: 35151397 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources